Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Grant | $43,777 | 1 | 98.6% |
| Food and Beverage | $627.45 | 29 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $43,835 | 5 | $0 (2024) |
| ABBVIE INC. | $195.95 | 11 | $0 (2024) |
| NOVARTIS PHARMACEUTICALS CORPORATION | $153.03 | 1 | $0 (2023) |
| Otsuka America Pharmaceutical, Inc. | $109.26 | 7 | $0 (2018) |
| Sandoz Inc. | $23.18 | 1 | $0 (2024) |
| Janssen Biotech, Inc. | $22.60 | 1 | $0 (2023) |
| Amgen Inc. | $19.29 | 1 | $0 (2018) |
| ConvaTec Inc. | $17.90 | 1 | $0 (2018) |
| AstraZeneca Pharmaceuticals LP | $16.68 | 1 | $0 (2018) |
| Cumberland Pharmaceuticals, Inc. | $11.51 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $43,863 | 5 | PFIZER INC. ($43,788) |
| 2023 | $280.93 | 8 | NOVARTIS PHARMACEUTICALS CORPORATION ($153.03) |
| 2022 | $85.75 | 6 | ABBVIE INC. ($73.81) |
| 2018 | $120.74 | 8 | Otsuka America Pharmaceutical, Inc. ($55.36) |
| 2017 | $53.90 | 3 | Otsuka America Pharmaceutical, Inc. ($53.90) |
All Payment Transactions
30 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/01/2024 | PFIZER INC. | — | Grant | Cash or cash equivalent | $43,776.76 | General |
| 02/20/2024 | ABBVIE INC. | HUMIRA (Biological), RINVOQ | Food and Beverage | In-kind items and services | $25.68 | General |
| Category: IMMUNOLOGY | ||||||
| 02/14/2024 | Sandoz Inc. | HYRIMOZ (Biological) | Food and Beverage | In-kind items and services | $23.18 | General |
| Category: Immunology | ||||||
| 01/26/2024 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $11.68 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 01/18/2024 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: IMMUNOLOGY | ||||||
| 11/12/2023 | NOVARTIS PHARMACEUTICALS CORPORATION | — | Food and Beverage | In-kind items and services | $153.03 | General |
| 10/06/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: IMMUNOLOGY | ||||||
| 09/13/2023 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: Immunology | ||||||
| 08/12/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $15.98 | General |
| Category: IMMUNOLOGY | ||||||
| 07/28/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: IMMUNOLOGY | ||||||
| 07/21/2023 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $18.91 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 03/31/2023 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.91 | General |
| Category: IMMUNOLOGY | ||||||
| 02/24/2023 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $15.52 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 12/09/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $12.73 | General |
| Category: IMMUNOLOGY | ||||||
| 12/02/2022 | PFIZER INC. | XELJANZ (Drug) | Food and Beverage | In-kind items and services | $11.94 | General |
| Category: GASTROINTESTINAL;INFLAMMATION;OPHTHALMOLOGY;TRANSPLANT | ||||||
| 11/19/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: IMMUNOLOGY | ||||||
| 10/15/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $16.73 | General |
| Category: IMMUNOLOGY | ||||||
| 10/01/2022 | ABBVIE INC. | SKYRIZI (Biological), RINVOQ | Food and Beverage | In-kind items and services | $14.13 | General |
| Category: IMMUNOLOGY | ||||||
| 07/22/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2018 | AstraZeneca Pharmaceuticals LP | BRILINTA (Drug) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/06/2018 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Food and Beverage | In-kind items and services | $11.33 | General |
| Category: NEPHROLOGY | ||||||
| 08/28/2018 | ConvaTec Inc. | AQUACEL AG (Device), AQUACEL | Food and Beverage | Cash or cash equivalent | $17.90 | General |
| Category: WOUND THERAPEUTICS | ||||||
| 08/22/2018 | Otsuka America Pharmaceutical, Inc. | JYNARQUE (Drug) | Food and Beverage | In-kind items and services | $12.41 | General |
| Category: NEPHROLOGY | ||||||
| 08/02/2018 | Otsuka America Pharmaceutical, Inc. | SAMSCA (Drug) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: NEPHROLOGY | ||||||
| 04/23/2018 | Cumberland Pharmaceuticals, Inc. | Caldolor (Drug) | Food and Beverage | In-kind items and services | $11.51 | General |
| Category: Anesthesiology (Pain Management) | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 3 | 59 | 59 | $82,885 | $8,890 |
| 2021 | 6 | 325 | 331 | $435,145 | $46,481 |
| 2020 | 3 | 85 | 85 | $120,870 | $13,517 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 29 | 29 | $40,584 | $4,226 | 10.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 16 | 16 | $24,759 | $2,685 | 10.8% |
| 99220 | Initial hospital observation care per day, typically 70 minutes | Facility | 2022 | 14 | 14 | $17,542 | $1,979 | 11.3% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 112 | 112 | $161,224 | $17,441 | 10.8% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2021 | 58 | 61 | $96,851 | $10,643 | 11.0% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2021 | 78 | 80 | $105,513 | $10,620 | 10.1% |
| 99219 | Hospital observation care, typically 50 minutes | Facility | 2021 | 46 | 46 | $44,376 | $4,776 | 10.8% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 15 | 15 | $14,583 | $1,613 | 11.1% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 16 | 17 | $12,599 | $1,388 | 11.0% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 37 | 37 | $53,262 | $5,889 | 11.1% |
| 99220 | Hospital observation care, typically 70 minutes | Facility | 2020 | 32 | 32 | $42,205 | $4,753 | 11.3% |
| 99291 | Critical care delivery critically ill or injured patient, first 30-74 minutes | Facility | 2020 | 16 | 16 | $25,404 | $2,875 | 11.3% |
About Dr. Mohammed Hamid, MD
Dr. Mohammed Hamid, MD is a Internal Medicine healthcare provider based in Caldwell, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/18/2017. The National Provider Identifier (NPI) number assigned to this provider is 1063942589.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohammed Hamid, MD has received a total of $44,404 in payments from pharmaceutical and medical device companies, with $43,863 received in 2024. These payments were reported across 30 transactions from 10 companies. The most common payment nature is "Grant" ($43,777).
As a Medicare-enrolled provider, Hamid has provided services to 469 Medicare beneficiaries, totaling 475 services with total Medicare billing of $68,888. Data is available for 3 years (2020–2022), covering 12 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Caldwell, NJ
- Active Since 06/18/2017
- Last Updated 12/31/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1063942589
Products in Payments
- RINVOQ (Biological) $156.14
- SAMSCA (Drug) $96.85
- XELJANZ (Drug) $58.05
- HUMIRA (Biological) $25.68
- HYRIMOZ (Biological) $23.18
- TREMFYA (Drug) $22.60
- AQUACEL AG (Device) $17.90
- BRILINTA (Drug) $16.68
- SKYRIZI (Biological) $14.13
- JYNARQUE (Drug) $12.41
- Caldolor (Drug) $11.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Caldwell
Bobby Chawla, D.o, D.O
Internal Medicine — Payments: $865,266
Dr. Lyndon Box, Md, MD
Internal Medicine — Payments: $6,421
Dr. Stanley Mayrowetz, Md, MD
Internal Medicine — Payments: $4,114
Dr. Mamatha Gadarla, M.d, M.D
Internal Medicine — Payments: $2,087
Nathanael Hogg, D.o, D.O
Internal Medicine — Payments: $1,626
Harsh Vardhan Agrawal, Md, MD
Internal Medicine — Payments: $763.10